- Home
- RNAZ vs SGLY Comparison
RNAZ vs SGLY Comparison
Compare RNAZ & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- SGLY
- Stock Information
- Founded
- RNAZ 2016
- SGLY 2001
- Country
- RNAZ United States
- SGLY United States
- Employees
- RNAZ N/A
- SGLY N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- SGLY
- Sector
- RNAZ Health Care
- SGLY
- Exchange
- RNAZ Nasdaq
- SGLY Nasdaq
- Market Cap
- RNAZ 7.2M
- SGLY 5.8M
- IPO Year
- RNAZ 2021
- SGLY 2008
- Fundamental
- Price
- RNAZ $8.08
- SGLY $0.83
- Analyst Decision
- RNAZ Strong Buy
- SGLY
- Analyst Count
- RNAZ 1
- SGLY 0
- Target Price
- RNAZ $20.00
- SGLY N/A
- AVG Volume (30 Days)
- RNAZ 4.3M
- SGLY 3.3M
- Earning Date
- RNAZ 03-31-2025
- SGLY 02-19-2025
- Dividend Yield
- RNAZ N/A
- SGLY N/A
- EPS Growth
- RNAZ N/A
- SGLY N/A
- EPS
- RNAZ N/A
- SGLY N/A
- Revenue
- RNAZ N/A
- SGLY $2,255,541.00
- Revenue This Year
- RNAZ N/A
- SGLY N/A
- Revenue Next Year
- RNAZ N/A
- SGLY N/A
- P/E Ratio
- RNAZ N/A
- SGLY N/A
- Revenue Growth
- RNAZ N/A
- SGLY N/A
- 52 Week Low
- RNAZ $2.66
- SGLY $0.66
- 52 Week High
- RNAZ $66.33
- SGLY $7.65
- Technical
- Relative Strength Index (RSI)
- RNAZ 48.31
- SGLY 36.06
- Support Level
- RNAZ $10.02
- SGLY $0.78
- Resistance Level
- RNAZ $11.30
- SGLY $0.95
- Average True Range (ATR)
- RNAZ 1.97
- SGLY 0.17
- MACD
- RNAZ -0.18
- SGLY -0.00
- Stochastic Oscillator
- RNAZ 26.75
- SGLY 18.80
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.